$ATRC News

AtriCure (NASDAQ:ATRC) Combines Technical Strength With a Breakout Setup

Citizens Maintains Market Outperform on AtriCure, Raises Price Target to $68

AtriCure to Announce Third Quarter 2026 Financial Results

BTIG Maintains Buy on AtriCure, Raises Price Target to $63

AtriCure (ATRC) Stock Gets Fair Value Bump As Analysts Weigh Procedure Growth And Risks

Freedom Capital Markets Downgrades AtriCure to Hold, Raises Price Target to $57

AtriCure (ATRC) Stock Looks Rich Against Its Sales Base

Why AtriCure (ATRC) Is Back In The Spotlight

Insider Selling: Regina E Groves Unloads $288K Of AtriCure Stock

Is AtriCure (ATRC) Stock Outpacing Its Medical Peers This Year?

AtriCure CTO Sells 3,657 Shares

Do Options Traders Know Something About AtriCure Stock We Don't?

Needham Maintains Buy on AtriCure, Raises Price Target to $64

Is AtriCure (ATRC) Outperforming Other Medical Stocks This Year?

Piper Sandler Maintains Overweight on AtriCure, Raises Price Target to $60

Karl S Dahlquist Implements A Sell Strategy: Offloads $458K In AtriCure Stock

AtriCure to Participate in the 2026 Wells Fargo Health Care Conference

BTIG Maintains Buy on AtriCure, Raises Price Target to $55

AtriCure: Promising Cardiovascular Surgical Platform

AtriCure Targets $1 Billion as Pain Management and AFib Trials Fuel Growth